Tyverb
Tyverb is a medicine authorised by Swissmedic under authorisation number 57937. The authorisation holder is Novartis Pharma Schweiz AG. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 23 May 2007 and the authorisation is valid without a time limit. ATC code L01EH01 places the medicine in the group Antineoplastic agents.
| Authorisation number | 57937 |
|---|---|
| Name | Tyverb |
| Full name | Tyverb, Filmtabletten |
| Authorisation holder | Novartis Pharma Schweiz AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | L01EH01 |
| First authorisation | 23 May 2007 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Tyverb, Filmtabletten | A | 23 May 2007 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 3 | 70 | Tablette(n) | L01EH01 | 07.16.1. | A |
| 4 | 2 X 70 | Tablette(n) | L01EH01 | 07.16.1. | A |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Tyverb authorised in Switzerland?
Yes. Tyverb is authorised by Swissmedic under authorisation number 57937, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Tyverb have?
Tyverb is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Tyverb?
The authorisation holder is Novartis Pharma Schweiz AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.